Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 1 5Phase 2 3Phase 3 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Breast 5Thoracic 3Other hematologic neoplasm 3Genitourinary 3CNS 3Tumor-Agnostic 2Sarcoma 2Plasma cell 2Lymphoid 2Gynecologic 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Blood Specimen Collection × Genitourinary × Clear all
NCT06904313 2025-06-04

Ultralow Dose PET Imaging for PSMA Expression

Nuclear Imaging Institute

Phase 2 Recruiting
200 enrolled
Genitourinary

Prostatic Neoplasms

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Thomas Jefferson University

Phase 2 Completed
14 enrolled 12 charts
Genitourinary

Carcinoma, Transitional Cell

NCT05241561 2022-06-01

Cabo-POLARIS

Centre Hospitalier Universitaire de Besancon

Phase 2 Not yet recruiting
24 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡